Benzyl 2-(((4aR,6R,7aR)-7,7-Difluoro-2-oxido-6-(2-oxo-4-propionamidopyrimidin-1(2H)-yl)tetrahydro-4H-furo[3,2-d][1,3,2]-dioxaphosphinin-2-yl)oxy)acetate

ID: ALA5270013

Chembl Id: CHEMBL5270013

Max Phase: Preclinical

Molecular Formula: C21H22F2N3O9P

Molecular Weight: 529.39

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(=O)Nc1ccn([C@@H]2O[C@@H]3COP(=O)(OCC(=O)OCc4ccccc4)O[C@H]3C2(F)F)c(=O)n1

Standard InChI:  InChI=1S/C21H22F2N3O9P/c1-2-16(27)24-15-8-9-26(20(29)25-15)19-21(22,23)18-14(34-19)11-32-36(30,35-18)33-12-17(28)31-10-13-6-4-3-5-7-13/h3-9,14,18-19H,2,10-12H2,1H3,(H,24,25,27,29)/t14-,18-,19-,36?/m1/s1

Standard InChI Key:  GANSGCHWTJNYMB-RGYFBUTASA-N

Alternative Forms

  1. Parent:

    ALA5270013

    ---

Associated Targets(Human)

MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 529.39Molecular Weight (Monoisotopic): 529.1062AlogP: 2.41#Rotatable Bonds: 8
Polar Surface Area: 144.28Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.37CX Basic pKa: CX LogP: 1.66CX LogD: 1.66
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.40Np Likeness Score: -0.30

References

1. Zhang L, Qi K, Xu J, Xing Y, Wang X, Tong L, He Z, Xu W, Li X, Jiang Y..  (2023)  Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine.,  66  (6): [PMID:36867101] [10.1021/acs.jmedchem.3c00006]

Source